NEW YORK, New York (The Adobo Chronicles® ) – Pfizer, the same drug manufacturing company that distributes viagra, the erectile dysfunction pill for men, has announced that it is now recruiting participants for Phase 3 clinical trials on a new investigative drug that could reverse homosexuality.
The New York-based company told reporters that it has successfully completed Phase 1 and Phase 2 of its clinical trials of a yet unnamed biochemical that would alter the Y chromosome in homosexual men.
In humans, a single gene (SRY) present on the Y chromosome acts as a signal to set the developmental pathway towards maleness. Presence of this gene starts off the process of virilization.
In earlier clinical trials, the biochemical has shown to activate the SRY gene that would restore the balance in the Y chromosome of gay men.
Phase 2 clinical trials results showed that 99.9% of the gay men in the study who were given the biochemical developed the SRY gene, compared to 0% of those who were given the placebo.
Pfizer is confident of continued success in its Phase 3 clinical trials and hopes to begin the process of applying for FDA marketing approval shortly after the conclusion of the trials.
Enrollment in the Phase 3 trials is ongoing. Gay men interested in participating in the trials are encouraged to call Pfizer or visit their website for more details.
Upon hearing of the Pfizer announcement, all of the Republican presidential candidates except for Ohio Governor John Kasich, congratulated the drug company for its overwhelming success in its Phase 2 and Phase 3 clinical trials for this anti-gay drug.
So if viagra is the purple pill, will the new anti-gay drug be the rainbow pill?